SDGR

MKT CAP:$869M

Schrödinger, Inc.

Market Cap

$869M

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$11.54-$6.44 (-35.82%)

Apr 24, 2026

Company Details

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug D...

CEO

Ramy Farid

IPO Date

Feb 6, 2020

Website

www.schrodinger.com

Key Metrics TTM

Revenue

$257M

+32.9% YoY

Net Income

-$176M

EPS (Diluted)

-$2.41

Free Cash Flow

-$3M

Revenue / Share

$3.49

Gross Margin

58.2%

Operating Margin

-66.3%

Net Margin

-68.5%

FCF Margin

-1.3%

P/S

3.4x

P/E

—

Earnings Reports

Q4 2025

May 6, 2026

PENDING

FY 2025

Feb 25, 2026

$256M+23.3%EPS -$1.41

Q3 2025

Nov 5, 2025

$54M+53.9%EPS -$0.45

Q2 2025

Aug 6, 2025

$55M+15.7%EPS -$0.59

Q1 2025

May 7, 2025

$60M+62.7%EPS -$0.82

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$46M	$26M	-$23M
Q1 22	$49M	$28M	-$29M
Q2 22	$38M	$17M	-$43M
Q3 22	$37M	$17M	-$46M
Q4 22	$57M	$39M	-$29M
Q1 23	$65M	$46M	-$31M
Q2 23	$35M	$14M	-$61M
Q3 23	$43M	$24M	-$56M
Q4 23	$74M	$58M	-$30M
Q1 24	$37M	$19M	-$67M
Q2 24	$47M	$31M	-$53M
Q3 24	$35M	$18M	-$68M
Q4 24	$88M	$64M	-$21M
Q1 25	$60M	$31M	-$51M
Q2 25	$55M	$26M	-$53M
Q3 25	$54M	$28M	-$46M

Valuation

Quarter	P/S	P/E
Q4 21	8.2x	—
Q1 22	6.1x	—
Q2 22	5.3x	—
Q3 22	5.1x	—
Q4 22	4.8x	—
Q1 23	4.4x	60.4x
Q2 23	4.5x	13.1x
Q3 23	4.4x	19.7x
Q4 23	4.0x	21.3x
Q1 24	4.6x	—
Q2 24	4.3x	—
Q3 24	4.5x	—
Q4 24	4.2x	—
Q1 25	3.8x	—
Q2 25	3.7x	—
Q3 25	3.4x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	-$20M	-$21M
Q1 22	-$40M	-$41M
Q2 22	-$25M	-$27M
Q3 22	-$30M	-$33M
Q4 22	-$25M	-$26M
Q1 23	-$31M	-$35M
Q2 23	-$18M	-$21M
Q3 23	-$50M	-$55M
Q4 23	-$37M	-$40M
Q1 24	-$39M	-$43M
Q2 24	-$54M	-$55M
Q3 24	-$33M	-$35M
Q4 24	-$31M	-$32M
Q1 25	$144M	$143M
Q2 25	-$52M	-$53M
Q3 25	-$62M	-$62M

Capital Expenditures

Quarter	CapEx
Q4 21	$957.0K
Q1 22	$2M
Q2 22	$2M
Q3 22	$3M
Q4 22	$1M
Q1 23	$4M
Q2 23	$2M
Q3 23	$5M
Q4 23	$2M
Q1 24	$4M
Q2 24	$1M
Q3 24	$1M
Q4 24	$873.0K
Q1 25	$596.0K
Q2 25	$314.0K
Q3 25	$491.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+208.5%	+185.4%
Q1 22	+274.5%	+234.3%
Q2 22	+120.1%	+213.3%
Q3 22	+23.9%	+28.9%
Q4 22	+23.1%	+24.3%
Q1 23	+33.1%	+23.3%
Q2 23	-8.5%	+17.5%
Q3 23	+15.1%	+18.8%
Q4 23	+30.4%	+21.5%
Q1 24	-43.5%	+9.2%
Q2 24	+34.5%	+3.9%
Q3 24	-17.1%	+5.0%
Q4 24	+19.1%	+5.1%
Q1 25	+62.7%	+6.2%
Q2 25	+15.7%	+7.6%
Q3 25	+53.9%	-3.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$7M	16.1%
Q1 22	$9M	18.8%
Q2 22	$10M	27.1%
Q3 22	$10M	26.7%
Q4 22	$10M	18.0%
Q1 23	$11M	16.8%
Q2 23	$12M	33.5%
Q3 23	$13M	29.7%
Q4 23	$13M	16.9%
Q1 24	$12M	33.4%
Q2 24	$13M	27.1%
Q3 24	$12M	35.1%
Q4 24	$12M	14.1%
Q1 25	$12M	19.4%
Q2 25	$11M	19.4%
Q3 25	$11M	20.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 21	$25M	$18M	$6M
Q1 22	$28M	$22M	$7M
Q2 22	$31M	$22M	$7M
Q3 22	$33M	$23M	$7M
Q4 22	$35M	$23M	$9M
Q1 23	$41M	$26M	$9M
Q2 23	$43M	$23M	$9M
Q3 23	$47M	$24M	$9M
Q4 23	$51M	$26M	$10M
Q1 24	$51M	$26M	$10M
Q2 24	$51M	$24M	$10M
Q3 24	$51M	$25M	$10M
Q4 24	$49M	$26M	$10M
Q1 25	$46M	$26M	$10M
Q2 25	$43M	$25M	$11M
Q3 25	$43M	$22M	$10M

Revenue by Geography

Quarter	Europe	Japan	Non Us	United States	Non-US	Apac	Emea
Q4 21	$9M	$2M	$3M	$32M	—	—	—
Q1 22	$13M	$2M	$4M	$30M	—	—	—
Q2 22	$5M	$3M	$3M	$27M	—	—	—
Q3 22	$4M	$2M	—	$27M	$4M	—	—
Q1 23	$7M	$4M	—	$50M	$3M	—	—
Q2 23	—	—	—	$24M	$156.0K	$6M	$5M
Q3 23	—	—	—	$33M	$117.0K	$6M	$4M
Q1 24	—	—	—	$23M	$604.0K	$6M	$7M
Q2 24	—	—	—	$31M	$121.0K	$9M	$8M
Q3 24	—	—	—	$25M	$243.0K	$5M	$5M
Q4 24	—	—	—	$36M	$250.0K	$6M	$46M
Q1 25	—	—	—	$30M	$731.0K	$6M	$23M
Q2 25	—	—	—	$34M	$175.0K	$7M	$14M
Q3 25	—	—	—	$31M	$515.0K	$7M	$16M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$117M	$408M	$526M
Q2 22	$127M	$382M	$510M
Q3 22	$103M	$371M	$474M
Q4 22	$90M	$361M	$451M
Q1 23	$233M	$294M	$528M
Q2 23	$286M	$263M	$549M
Q3 23	$249M	$247M	$496M
Q4 23	$161M	$308M	$469M
Q1 24	$130M	$301M	$431M
Q2 24	$108M	$269M	$377M
Q3 24	$160M	$228M	$389M
Q4 24	$147M	$205M	$352M
Q1 25	$326M	$174M	$500M
Q2 25	$220M	$230M	$450M
Q3 25	$182M	$219M	$401M
Q4 25	$231M	$165M	$395M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	71M	0.0%	+1134.8%
Q1 22	71M	+0.4%	+46.6%
Q2 22	71M	+0.2%	+46.8%
Q3 22	71M	+0.1%	+0.6%
Q4 22	71M	+0.2%	+0.8%
Q1 23	74M	+3.5%	+3.9%
Q2 23	75M	+1.7%	+5.5%
Q3 23	72M	-4.2%	+1.0%
Q4 23	72M	+0.3%	+1.2%
Q1 24	72M	+0.2%	-2.1%
Q2 24	73M	+0.6%	-3.1%
Q3 24	73M	+0.1%	+1.2%
Q4 24	73M	-0.2%	+0.7%
Q1 25	73M	+0.5%	+1.1%
Q2 25	73M	+0.5%	+1.0%
Q3 25	74M	+0.3%	+1.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$69.5K	664
Q1 22	$73.3K	664
Q2 22	$57.9K	664
Q3 22	$55.7K	664
Q4 22	$72.2K	787
Q1 23	$82.3K	787
Q2 23	$44.7K	787
Q3 23	$54.1K	787
Q4 23	$85.5K	867
Q1 24	$42.2K	867
Q2 24	$54.6K	867
Q3 24	$40.7K	867
Q4 24	$99.1K	891
Q1 25	$66.8K	891
Q2 25	$61.5K	891
Q3 25	$61.0K	891

Revenue / Employee